|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
Problems in humans have not been documented.
|
|
INDICATIONS:
|
|
|
|
SIDE EFFECTS:
|
|
Risk-benefit should be considered when the following medical problem exists |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
|
|
ADULT DOSE:
|
|
Antiflatulent-
Oral, 40 to 125 mg four times a day, after meals and at bedtime, or as needed ; or, 150 mg three times a day, after meals , or as needed.
Note: For OTC use, it is recommended that no more than 500 mg be taken in each twenty-four-hour period. |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Dosage must be individualized by physician.
|
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
Antiflatulent-
Oral, 40 to 125 mg four times a day, after meals and at bedtime, or as needed ; or, 150 mg three times a day, after meals , or as needed.
Note: For OTC use, it is recommended that no more than 500 mg be taken in each twenty-four-hour period. |
|
|
|
|
|